Long-term safety and efficacy of sirukumab for patients with rheumatoid arthritis who previously received sirukumab in randomised controlled trials (SIRROUND-LTE).
Daniel AletahaClifton O BinghamGeorge Athanasios KarpouzasTsutomu TakeuchiCarter ThorneAndroniki BiliPrasheen AgarwalBenjamin HsuRavi RaoKurt BrownYoshiya TanakaPublished in: RMD open (2021)
NCT01856309.
Keyphrases